Israel's Teva Pharmaceutical Industries Ltd. said Monday it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion, in what Israeli analysts called the largest-ever acquisition by an Israeli company.
Source :CBC | Business News http://ift.tt/1IC9NoW
0 commentaires:
Enregistrer un commentaire